by Bayerisches-ZKF-30-03-20 | Aug 14, 2023 | News
In the Bavarian Cancer Research Center (BZKF), the six Bavarian university hospitals and their respective universities have joined forces to form a strong alliance. Since 2019, the BZKF has been pursuing the goal of bringing innovative therapeutic approaches from...
by Franziska Klein | Jun 28, 2023 | News
Munich, March 06, 2023 On February 28, 2023, a working group of pharmaceutical companies with a focus on oncology and the Bavarian Cancer Research Center (BZKF) adopted a standardized contract template for clinical trials in oncology. The aim of this model contract,...
by Franziska Klein | Feb 24, 2022 | Forschung, News
Multiple types of genomic aberrations occur in cutaneous melanoma, and some can impact the prognosis of the disease. Hence, the integration of genomics data with clinical outcome could facilitate the identification of the most relevant genomic features for melanoma...
by Bayerisches-ZKF-30-03-20 | Jul 2, 2020 | News
Background: The most important pillar of a curative treatment of colorectal liver metastases is surgical liver resection. If the complete removal of the liver metastases is successful, a 5-year survival of 55-67% is achievable, but in many patients a complete...
by Bayerisches-ZKF-30-03-20 | Jul 1, 2020 | News
The diagnosis of cancer, which is given annually to more than 230,000 women in Germany, means not only the struggle with survival, but also a daily struggle with the mirror image. Due to hair loss, loss of eyelashes and eyebrows or skin irritations – caused by...
by Bayerisches-ZKF-30-03-20 | Jul 1, 2020 | News
At the end of 2019, the first successes in the treatment of beta-thalassemia patients with the CRISPR/Cas9 procedure at the University Hospital Regensburg (UKR) were achieved. In a further study, gene therapy in the field of sickle cell diseases was investigated, and...
Recent Comments